Skip to content
Fiscal Receipts

Senate LDA lobbying filing

CARDINAL HEALTH INC

Registrant: CARDINAL HEALTH, INC. Year: 2025 Period: Fourth Quarter Type: Q4

View on lda.senate.gov ↗

Reported income

not reported

Reported expenses

$740.0K

Tracked program mentions1

Quoted activity text is clipped to a short extract; each filing’s full description is under Lobbying activities below.

Lobbying activities4

  • Health IssuesHCR

    Issues related to drug pricing, bona fide service fees, Affordable Care Act subsidies, pharmacies, provider status, biosimilars, cell and gene therapy, food is medicine; issues related to provider reimbursement, Medicare and Medicaid, workforce shortages, and product shortages (H.R.4299 Protecting Patient Access to Cancer and Complex Therapies Act; H.R.5031 Preserving Patient Access to Long-Term Care Pharmacies Act; H.R.3164/S.2426 Ensuring Community Access to Pharmacist Services Act). Issues related to DMEPOS supplies, competitive bidding, reimbursement to home health agencies, and acute hospital care at home services (H.R.5142 Home Health Stabilization Act of 2025; H.R. 4313 Hospital Inpatient Services Modernization Act).

  • ManufacturingMAN

    Education on supply chain issues, drug shortages, domestic manufacturing, medical device environmental issues; Issues related to the medical supply chain and transportation.

  • Tariff (miscellaneous tariff bills)TAR

    Issues related to tariffs, trade, and U.S. trade policy.

  • Trade (domestic/foreign)TRD

    Issues related to tariffs, trade, and U.S. trade policy.

Lobbyists4

  • ABIGAIL BARNES
  • ANGELEINE COMTE
  • JERRICA MATHIS
  • REBECCA MCGRATH

Source: U.S. Senate Lobbying Disclosure Act database. Dollar figures (underlined) cite the filing record on lda.senate.gov — click to view the citation. Amounts shown as “not reported” are absent from the filing itself.